1125345 - Macrogenics Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - MGNX (1125345)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
44 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P1+8-3+16+74
S8+0+3-1-25

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

AD
2018-01-24
MGNXRisser Eric BlasiusSVP, Chief Business OfficerM - OptEx$0.94+3,0009,100+49%+$2,820
AD
2018-01-24
MGNXRisser Eric BlasiusSVP, Chief Business OfficerS - Sale+OE$22.50-3,0009,100-25%-$67,500
D
2018-01-24
MGNXRisser Eric BlasiusSVP, Chief Business OfficerM - OptEx$0.94+3,0009,100+49%+$2,820
D
2018-01-24
MGNXRisser Eric BlasiusSVP, Chief Business OfficerS - Sale+OE$22.50-3,0009,100-25%-$67,500
D
2018-01-16
MGNXKarrels JamesSVP, CFO, SecretaryM - OptEx$0.94+6,516119,847+6%+$6,125
DM
2018-01-16
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+5,00030,000+20%+$23,500
DM
2018-01-16
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$20.00-5,00030,000-14%-$100,000
D
2018-01-17
MGNXRisser Eric BlasiusSVP, Chief Business OfficerM - OptEx$0.94+2,0009,100+28%+$1,880
D
2017-12-29
MGNXKarrels JamesSVP, CFO, SecretaryM - OptEx$0.94+3,000113,331+3%+$2,820
D
2017-11-21
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+5,00030,000+20%+$23,500
D
2017-11-21
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$20.00-5,00030,000-14%-$100,000
D
2017-10-25
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+10,00030,000+50%+$47,000
D
2017-10-25
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$20.00-10,00030,000-25%-$200,000
D
2017-09-05
MGNXKarrels JamesSVP, CFO, SecretaryM - OptEx$0.94+5,000110,331+5%+$4,700
D
2017-09-05
MGNXRisser Eric BlasiusSVP, Chief Business OfficerM - OptEx$0.94+2,0006,000+50%+$1,880
D
2017-07-26
MGNXBonvini EzioSVP, Research, CSOM - OptEx$1.23+53,264146,658+57%+$65,248
D
2017-06-05
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+5,00030,000+20%+$23,500
D
2017-06-05
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$20.00-5,00030,000-14%-$100,000
2017-04-28
MGNXSaran AtulSVP, GCF - Tax$21.61-1,86216,986-10%-$40,238-3-15
D
2017-04-19
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+15,00030,000+100%+$70,500-1+4
D
2017-04-19
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$20.00-15,00030,000-33%-$300,000-1+4
D
2017-01-25
MGNXKarrels JamesSVP, CFO, SecretaryM - OptEx$0.94+5,000105,331+5%+$4,700+1+1+7
D
2017-01-17
MGNXKoenig ScottPres, CEOM - OptEx$0.94+79,8981,004,358+9%+$75,104+1-4+9
DM
2016-02-11
MGNXBonvini EzioSVP, Research, CSOM - OptEx$0.94+17,311100,944+21%+$16,272-1-7+10-18
AD
2016-10-03
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+10,0000-100%+$47,000+4+2+18-14
AD
2016-10-03
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$29.34-10,0000-100%-$293,400+4+2+18-14
D
2016-10-03
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+10,0000-100%+$47,000-1-2-28-43
D
2016-10-03
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$29.34-10,0000-100%-$293,400-1-2-28-43
D
2016-10-03
MGNXCilinski LynnVP, Controller, TreasurerM - OptEx$0.94+6,2311,923-145%+$5,857-1-2-28-43
D
2016-10-03
MGNXCilinski LynnVP, Controller, TreasurerS - Sale+OE$29.28-6,2311,923-76%-$182,444-1-2-28-43
D
2016-08-01
MGNXWigginton Jon MarcSVP Clinical Dev, CMOM - OptEx$4.70+20,0000-100%+$94,000+2-1-6-44
D
2016-08-01
MGNXWigginton Jon MarcSVP Clinical Dev, CMOS - Sale+OE$30.78-20,0000-100%-$615,600+2-1-6-44
D
2016-07-01
MGNXWigginton Jon MarcSVP Clinical Dev, CMOM - OptEx$4.70+5,0000-100%+$23,500-1+5+21-24
D
2016-07-01
MGNXWigginton Jon MarcSVP Clinical Dev, CMOS - Sale+OE$27.22-5,0000-100%-$136,100-1+5+21-24
D
2016-07-01
MGNXCilinski LynnVP, Controller, TreasurerM - OptEx$0.94+8,9221,923-127%+$8,387-1+5+21-24
D
2016-07-01
MGNXCilinski LynnVP, Controller, TreasurerS - Sale+OE$27.22-8,9221,923-82%-$242,857-1+5+21-24
A
2016-04-28
MGNXSaran AtulSVP, GCF - Tax$20.84-1,86218,848-9%-$38,804+1+9+5+7
D
2016-05-27
MGNXCilinski LynnVP, Controller, TreasurerM - OptEx$0.94+5,0001,923-162%+$4,700+2+10-4+17
D
2016-05-27
MGNXCilinski LynnVP, Controller, TreasurerS - Sale+OE$25.00-5,0001,923-72%-$125,000+2+10-4+17
D
2016-05-16
MGNXKoenig ScottPres, CEOM - OptEx$0.94+34,619924,460+4%+$32,542-1+24+40+63
D
2016-05-11
MGNXKoenig ScottPres, CEOM - OptEx$0.94+79,898889,841+10%+$75,104+3+27+57+61
2016-04-28
MGNXSaran AtulSVP, GCF - Tax$20.84-1,73018,980-8%-$36,053-1-10+18+18
2016-03-03
MGNXCosta Paulo FDirP - Purchase$17.20+10,00059,435+20%+$172,000+8-3+16+74
2016-02-25
MGNXWigginton Jon MarcSVP, Clinical Dev, CMOA - Grant$0.00+30,00030,000New+$0+1+18+8+85

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top